Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Announcing the Launch of RealHealthSavings.com
Announcing the launch of RealHealthSavings.com: a free resource to access major savings on drugs and other medical needs. - March 25, 2008 - Real Health Savings LLC
National Courses Taught by Former FDA Investigators Examine Latest Strategies for Integrating Quality and Risk Management
A series of FDA compliance training courses taught by former FDA investigators will examine the regulations and best practices for integrating quality and risk management. Courses will be held in Charlotte, NC, and Providence, RI. - March 24, 2008 - EduQuest Inc.
LegalView Updates Baxter Heparin Portal with Information on the Source of Contamination for the Recalled Blood-Thinning Drug
LegalView updated its readers on the latest Baxter Heparin news from the FDA, which discovered the source of contamination of the blood-thinning agent to be a Chinese manufacturer. An investigation is underway to determine if the manufacturer intentionally compromised the safety of patients by using a less expensive derivative in the injectable drug. - March 23, 2008 - LegalView
GTCbio Announces Its 4th Modern Drug Discovery and Development Summit Taking Place on October 15-17, 2008 in San Diego, CA
GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA. Now in its fourth year, the summit will once again provide a landscape and in-depth industry analysis streaming through different therapeutic and target areas and examining the current advancements and where we’re headed in the coming years. - March 23, 2008 - GTCbio
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
First New Agent for CLL Patients Approved by the FDA since 2001 - March 21, 2008 - Cephalon
Biopharma Innovators Syntaxin Wins Top Honours at 2007 Interactive Media Awards
Biopharma firm Syntaxin's new website has won a very prestigious IMA award which recognises great design, technical innovation and accessibility compliance within the interactive media industry. - March 19, 2008 - Syntaxin Ltd
RNCOS Releases Report on Indian Pharma Sector Analysis
The market research report “Indian Pharma Sector Analysis” by RNCOS is detailed study of the Indian pharmaceutical market. - March 17, 2008 - RNCOS
LegalView is Proud to Announce the Launch of New FDA Notification Service
LegalView recently launched its U.S. Food and Drug Administration (FDA) notification service, which will allow individuals suffering from negative pharmaceutical side effects to voice their concerns directly to the FDA. LegalView currently offers a vast plentitude of practice areas relating to adverse pharmaceutical side effects but now readers will be able to take immediate action. - March 15, 2008 - LegalView
SecureRF to Present “What Do We Really Mean by Security for RFID -- And How Much is Enough” at INTERPHEX 2008 Pharmaceutical Conference
Louis Parks, CEO of SecureRF, to Present “What Do We Really Mean By Security for RFID -- And How Much Is Enough” on March 26, 2008 at 2 PM at INTERPHEX 2008 pharmaceutical conference in Philadelphia. Parks to detail RFID Security functions for pharmaceutical applications. - March 14, 2008 - SecureRF Corporation
Safety Stressed in Updated Guidance on Methadone for the Relief of Chronic Pain
Essential guidance for practitioners on safely prescribing methadone for patients with chronic pain, along with special instructions for patients on how to avoid methadone adverse events or overdose, are available in two new documents exclusively from Pain Treatment Topics. - March 13, 2008 - Pain Treatment Topics
NCSRT Launches DiaSync for Improved Yield, Lower Cost in Harvest, Concentration, and Diafiltration of Biomolecules
At the Antibody Development and Production meeting in San Diego, CA March 12, 2008, NCSRT is launching its DiaSync process for biomolecules from fermentation, cell culture, or extraction. Utilizing concurrent processing technology and the patented SmartFlow™ TFF technology, DiaSync provides... - March 12, 2008 - NCSRT, Inc.
Basel Life Forum Launches on BioValley.ch with Partner glocals.com; Win iPhone
BioValley.ch announces the launch of Basel Life in partnership with glocals.com, which offers forums and networking platforms in several cities and regions in Switzerland. Basel Life targets a business and academic audience, which is interested in sharing Best Business Practices, strengthening... - March 09, 2008 - BioValley.ch
Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18
Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA - March 08, 2008 - GTCbio
Life is Good RX Announces Free Prescription Plan
The Life is Good Rx program will provide on the spot price reductions of up to 75% percent on commonly used prescription drugs. Any resident of the United States is eligible to receive a card, it is completely free of charge and there are no burdensome qualification criteria or application processes. Savings are calculated instantly at the time of purchase. - March 07, 2008 - Life is Good Prescription Plan
FDA Approves Pristiq for the Treatment of Adult Patients with Major Depressive Disorder
The FDA has approved PRISTIQ (desvenlafaxine), an SNRI, to treat adult patients with major depressive disorder (MDD). Wyeth expects to begin shipping PRISTIQ to wholesalers beginning in the second quarter of 2008. - March 01, 2008 - Wyeth Pharmaceuticals
Silicone Pump Tubing Now Offers USP Class VI Approval; Ideal for Pharmaceutical, Biotech & Lab Use
AdvantaPure’s platinum-cured silicone pump tubing, called APSPG, now carries Class VI approval to assure users of the product’s purity in critical applications such as those in the pharmaceutical and biomedical fields. APSPG is designed and manufactured to far outlast standard silicone tubing in peristaltic pump applications. The tubing withstands repeated compression and release, resulting in steady fluid flow rates. Sizes from .031” through .500” I.D. are stocked for immediate or JIT shipment. - March 01, 2008 - NewAge Industries, Inc.
Octagon Research Solutions Inc. to Exhibit at the Drug Information Association 20th Annual EuroMeeting
CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a leader in the electronic transformation of clinical R&D in the life sciences industry, today announced that Octagon will be exhibiting at the Drug Information Association’s (DIA) 20th Annual EuroMeeting. This year, the... - February 29, 2008 - Octagon Research Solutions, Inc
ClinfoSource and Nucleus Network Jointly Launch On-Line GCP Clinical Trials Training Programs for the Australia-New Zealand Region
ClinfoSource, a US-based global online training company has partnered with Nucleus Network of Australia to provide web-based GCP training for clinical trials professionals in the Australia region, later to be extended to include New Zealand regulations. This program will offer clinical trial investigators, coordinators, research associates and others a solid and practical understanding of clinical trials conduct and management, the regulations and ethics central to the drug development process. - February 28, 2008 - ClinfoSource
RNCOS Releases Report on Generic Drugs Market in Brazil
Brazil, one of the major emerging powers of the world, is marking its presence in almost every dimension of the world economy, including the generic drugs industry. Identifying the importance of the country in this significant domain, the leading market research firm, RNCOS, has come up with... - February 23, 2008 - RNCOS
Clinical Trials in Russia, 4th Quarter 2007
On February 18, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various aspects... - February 20, 2008 - Synergy Research Group
SinuPulse Elite Advanced Nasal Sinus Irrigation System for Proven Drug Free Allergy and Sinus Relief. Now Available Nationally.
The SinuPulse Elite Advanced Nasal Sinus Irrigation System is recommended by leading healthcare professionals for the treatment of allergy symptoms, sinusitis, post nasal drip, infections, and sinus headaches. - February 09, 2008 - Health Solutions Medical Products Corp
China-AsiaStocks.com Reports on Healthcare Opportunities in China
Benda Pharmaceutical Capitalizes on Accelerated Healthcare Spending in China and Growing Opportunities for Gendicine® Cancer Treatment - February 06, 2008 - InvestorIdeas.com
Octagon Releases StartingPoint(R) 3.0
Latest version of template suite provides quality assurance and authoring process enhancements. - February 06, 2008 - Octagon Research Solutions, Inc
Dr. John Abramson to Join Politickin Radio in Uncovering the Dark Side of the Pharmaceutical Industry
Harvard Medical School professor and author of "Overdosed America," Dr. John Abramson joins Politickin Radio as a guest to discuss the shortcomings of the American Medicine. - February 01, 2008 - Politickin Radio
Xcelience Expands Its Early Drug Development Capabilities
The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC
Expert Venture Capitalists Panel to Discuss Investment Opportunities at Anti-Infectives Partnering & Deal-Making Summit (Mar. 5-7, Philadelphia)
2005’s new trend of Big Pharma acquisitions of small companies developing monoclonal antibodies has sparked a renewed interest for investors in the anti-infectives space. Four leading expert Venture Capitalists will meet to discuss the various investment opportunities in infectious diseases... - January 26, 2008 - GTCbio
Director of NIBIB to Give Keynote Talk at 3rd Imaging in Drug Development Conference – Mar. 17-18, San Diego
Roderic Pettigrew, Director at the National Institute of Biomedical Imaging & Bioengineering, NIH will give the keynote presentation at GTCbio’s 3rd Imaging in Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Pettigrew will discuss the importance of imaging in 21st... - January 26, 2008 - GTCbio
Chief Scientist at the NCI to Speak at 3rd Imaging in Drug Development Conference - March 17-18, San Diego
Dr. Hisataka Kobayashi, Chief Scientist of Molecular Imaging at the National Cancer Institute will speak at GTCbio’s 3rd Imaging in Pre-clinical & Clinical Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Kobayashi will discuss environment sensitive "smart"... - January 26, 2008 - GTCbio
GTCbio Announces Its 4th International Stem Cell Research & Therapeutics Conference
GTCbio announces the 4th International Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA – featuring a keynote presentation from the Rudolf Jaenisch, a Founding Member of Whitehead Institute, a pioneer of transgenic science, and a leader in the field of therapeutic cloning, also called nuclear transfer. - January 26, 2008 - GTCbio
Sanofi-Aventis to Present at GTCbio’s 4th Stem Cell Research & Therapeutics- April 17-18, Boston
Dr. Christophe Labie, Group Leader of the Molecular Neurobiology Group at Sanofi-Aventis will give a presentation entitled “Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain” at GTCbio’s 4th Stem Cell Research & Therapeutics on April... - January 24, 2008 - GTCbio
Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008
Anavex Life Sciences Corp. achieved significant development of its lead drug candidates and growth of its management and scientific teams during 2007. - January 24, 2008 - Anavex Life Sciences Corp.
Octagon to Present at 21st Annual DIA Conference for Electronic Document Management
Company Thought Leaders Participate in Programming and Presentations. - January 24, 2008 - Octagon Research Solutions, Inc
AdvantaPure(R) Introduces Single Use Process Systems for the Pharmaceutical Industry
Cost-saving Single Use Process Systems of silicone tubing, molded silicone components, and parts such as bags and bottles are now available from AdvantaPure. The systems reduce contamination risks, simplify cleaning procedures, and offer design flexibility. Tubing and components are cleanroom manufactured and assembled. Gamma irradiatable RFID tags may be attached to systems for reliable electronic identification. - January 24, 2008 - NewAge Industries, Inc.
Anatstat Health Education Media Promotes and Expands
Anatstat Health Education Media, a health education company that specializes in developing interactive patient education materials, announced today that Jonas Tolliver and Scott Romer have accepted positions as Account Executives. Mr. Tolliver comes to Anatstat with over 5 years of successful... - January 22, 2008 - Anatstat USA Health Education Media
Testing Laboratory Software for Pharmaceutical & Chemical Industries
Marg Compusoft Pvt. Ltd. an ISO Certified Company and a computer software provider, especially for Pharmaceuticals & Chemicals Industries, launched Testing Laboratory Software. A few of its features are given below for your references. * Entry Register, Sample Register * Quality Control... - January 17, 2008 - Marg Compusoft Pvt. Ltd.
Anavex Strengthens Board of Directors
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.
Pharma Diversity Job Board Selects eJobFairs.net as Partner
PharmaDiversity Job Board to offer electronic job fairs powered by eJobFairs.net. - January 11, 2008 - eJobFairs.net LLC
Joint Presentation from Boehringer Ingelheim and Biota at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA)
James Chafouleas, Director of Global Licensing – Virology at Boehringer Ingelheim and Leigh Farrell, Vice President of Business Development at Biota will give a joint presentation entitled “Making the Right Deal: It’s Not Just About the Money” at GTCbio’s 5th... - January 09, 2008 - GTCbio
Axium Awarded Phase III Clinical Trial Management Contract for OxThera’s Oxabact™
Axium Healthcare Pharmacy announced today that it has been awarded the clinical trial management contract for OxThera’s Oxabact™. Oxabact™ is manufactured by OxThera. - January 09, 2008 - Axium Healthcare Pharmacy, Inc.
University of Massachusetts to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Eicke Latz, Assistant Professor in Medicine of the Division of Infectious Diseases and Immunology at University of Massachusetts Medical School will give a presentation entitled “Mechanisms of Crystal Recognition by Inflammasomes” at GTCbio’s 6th Cytokines and Inflammation... - January 09, 2008 - GTCbio
Director, Molecular Imaging at GSK to speak at 3rd Imaging in Drug Development conference March 2008
Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Sarkar will present on molecular imaging approaches to in vivo pharmacokinetic and... - January 09, 2008 - GTCbio
Joint Presentation from Novartis and Human Genome Sciences at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA)
Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at Novartis and Margery B. Fischbein, Vice President of Business Development & Strategic Planning at Human Genome Sciences will give a joint presentation at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit taking... - January 09, 2008 - GTCbio
CEO of ChemoCentryx to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Thomas Schall, President & CEO of ChemoCentryx will give a presentation entitled “Inhibition of CCR9 as a Therapeutic Approach: Beyond the Small Intestine” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.) CCR9 is a chemokine receptor known... - January 09, 2008 - GTCbio
Genentech to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Dimitry M. Danilenko, Senior Pathologist of the Department of Pathology at Genentech will give a presentation entitled “IL-22, a Th17 Cytokine, Plays an Important Role in Psoriasis as well as in Mucocutaneous Host Defense” at GTCbio’s 6th Cytokines and Inflammation (January 28-29,... - January 09, 2008 - GTCbio
Chief, Diagnostic Radiology at NIH to Speak at 3rd Imaging in Drug Development Conference March 2008
Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology at NIH will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Frank will present on using MRI to monitor cellular therapy. Magnetic labeling of cells... - January 09, 2008 - GTCbio
Biogen-Idec to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Shelia Violette, Director of Discovery Immunology at Biogen-Idec will give a presentation entitled “The Alphavbeta6 Integrin: A Mediator of TGF-Beta Activation and Therapeutic Target in Fibrosis and Oncology” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008,... - January 09, 2008 - GTCbio
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals
Schering Plough to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Jianhua Chao, Principal Scientist of Discovery Chemical Research at Schering-Plough will give a presentation entitled “Potent, Orally Active CXCR2-CXCR1 Antagonists as Anti-inflammatory Therapy” at GTCbio’s 6th Cytokines and Inflammation. (January 28-29, 2008, Orlando,... - January 07, 2008 - GTCbio